ATTD 2022: Dexcom EVP Discusses New Portfolio, Research, Increasing The Market Of CGMs

Chad Patterson, Dexcom’s executive vice president of global marketing and product management, talked to Medtech Insight about the premium continuous glucose monitor manufacturer’s plans for facing stiff competition over the coming years.

Dexcom's G6 sensor • Source: Alamy

Dexcom is right on the precipice of launching its new G7 continuous glucose monitor in the US, following its recent CE marking in Europe.

More from Clinical Trials

More from R&D